JAC Advance Access originally published online on February 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 600-603
© 2004 The British Society for Antimicrobial Chemotherapy
Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide
1 Section of Microbiology and Infectious Diseases, Kaohsiung Veterans General Hospital, 386 Ta-Chung 1st Rd, Kaohsiung; 2 Department of Medical Technology, Foo-Yin Institute of Technology, Kaohsiung; 3 Graduate Institute of Environmental Education, National Kaohsiung Normal University; 4 Department of Medicine, National Yang Ming University, Taipei, Taiwan, ROC
Received 10 September 2003; returned 29 October 2003; revised 15 December 2003; accepted 18 December 2003
Objectives: Tentative standards for testing MICs for Mycobacterium tuberculosis include agar dilution and the BACTEC method. However, the conventional agar dilution method requires 3–5 weeks to complete; whereas BACTEC, although a rapid test, involves the use of radioisotopes. In contrast, the MGIT 960 system uses a fluorescence quenching based oxygen sensor that can be read automatically. This system is not only robust, safe and simple, but has been validated for susceptibility tests of first-line antituberculous agents.
Methods: We evaluated 46 clinical strains of M. tuberculosis isolated from patients admitted to Kaohsiung Veterans General Hospital. Testing of MICs of ciprofloxacin and ethionamide was carried out by MGIT 960 and compared with the agar dilution method.
Results: Good agreement was found between MGIT 960 and agar dilution. The greatest concordance between the agar dilution and MGIT assay at ±1 and ±2 dilution was 80.4% and 97.8% for ciprofloxacin, and 82.6% and 93.5% for ethionamide, respectively.
Conclusion: MGIT 960 was found to be comparable to the current NCCLS standard method, agar dilution, and has the advantage of being rapid (obtaining results within 5–17 days, average 8.9 days) and easy to achieve standardization.
Keywords: minimum inhibitory concentration, M. tuberculosis, susceptibility testing
* Corresponding author. Tel: +886-7-3468098; Fax: +886-7-3468296.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Springer, K. Lucke, R. Calligaris-Maibach, C. Ritter, and E. C. Bottger Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation J. Clin. Microbiol., June 1, 2009; 47(6): 1773 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rusch-Gerdes, G. E. Pfyffer, M. Casal, M. Chadwick, and S. Siddiqi Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer Antimicrobials. J. Clin. Microbiol., March 1, 2006; 44(3): 688 - 692. [Abstract] [Full Text] [PDF]
|
|